Amino acids potently stimulate glucagon secretion, but their mechanisms of action remain largely unknown. To assess the effects of individual amino acids on α-cell Ca2+, we used GcgCreERT:GCaMP6s Ca2+ reporter. We focused on alanine, arginine, glutamine, and leucine, which have the potential to affect Ca2+ and glucagon release via their transport or metabolism. Under hypoglycemic conditions, when β-cells are inactive, alanine and arginine provoked a sustained increase in α-cell Ca2+, while the mitochondria fuels glutamine and leucine lowered Ca2+ after alanine and arginine are applied. However, when applying these four amino acids simultaneously, Ca2+ influx is increased above that stimulated by arginine and alanine alone, suggesting the effect of mitochondria fuels on Ca2+ is membrane-potential dependent. Phosphoenolpyruvate (PEP) cycle can be fueled by mitochondria fuels and potentially affects KATP channels via the ATP-generating enzyme pyruvate kinase (PK). To test this hypothesis, we used CRISPR to generate mice lacking the mitochondrial PEP-generating enzyme PCK2 in α-cells (GcgCreERT:Pck2f/f:GCaMP6s). PEP cycle ablation increased Ca2+ influx stimulated by alanine and arginine, much more strongly when leucine and glutamine were provided as mitochondria fuels. Pharmacological activation of PK reduces amino acid-stimulated Ca2+ influx. Taken together, the effect of mitochondria fuels on α-cell Ca2+ is most likely membrane potential dependent, and α-cell PEP cycle is an inhibitory pathway that lowers Ca2+ influx stimulated by amino acids.

Disclosure

E. Jin: None. H.R. Foster: None. E. Potapenko: None. E.R. Knuth: None. M.J. Merrins: None.

Funding

The Merrins laboratory gratefully acknowledges support from the NIH/NIDDK (R01DK113103 and R01DK127637 to MJM) and the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service (I01BX005113 to MJM). ERK received a predoctoral fellowship from the NIH/NIDDK (F31DK134171).

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.